# IO Vancomycin Into the Medial Malleolus vs IV Administration in Revision TKA

> **NCT07283068** · NA · NOT_YET_RECRUITING · sponsor: **The Methodist Hospital Research Institute** · enrollment: 40 (estimated)

## Conditions studied

- Revision Total Knee Arthroplasty

## Interventions

- **DRUG:** Intraosseous Vancomycin

## Key facts

- **NCT ID:** NCT07283068
- **Lead sponsor:** The Methodist Hospital Research Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-15
- **Primary completion:** 2030-02-15
- **Final completion:** 2030-06-15
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07283068

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07283068, "IO Vancomycin Into the Medial Malleolus vs IV Administration in Revision TKA". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07283068. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*